Diseases :P Flashcards
The Berlin patient
-first person cured of HIV (stem cell transplants)
-London patient, city of hope, and New York patient followed
stem cell transplants
-aka bone marrow transplant
-high risk
-used to treat blood cancer, received HIV-resistant mutation from donors
-deletes protein virus uses to enter blood
cells
1920 (HIV)
-Democratic Republic of Congo
-HIV cross species from chimps to humans
HIV-1
-primary HIV
-worldwide
-99% cases genetically related to Simian Immunodeficiency Virus (SIV) carried by chimps
HIV-2
-weakly contagious
-not often found outside Africa
-closely related to SIV (SIVcpz infects chimps)
-only 1% of people with HIV in the US have this type
HIV origin
-In chimps in Central Africa may have crossed to humans in the 1800s
-SIV is chimp version of HIV
-crossover when hunted chimps and contact infected blood
-HIV spread over Africa and then to other parts of the world
-in US since mid/late 1970s
HIV classification and virus description
-family: Retroviridae
-genus: Lentivirus
-enveloped with ssRNA
HIV virions have
-2 identical ssRNA
-reverse transcriptase, integrase, protease, and an envelope
-envelope spikes termed gp120 (combine with CD4 receptor on T helper cells, target of HIV)
reverse transcriptase
-enzyme
-RNA template to synthesize DNA
-high error rate
HIV resistance
-resistance to HIV-1 is rare
-“exposed-uninfected”: despite repeated exposure may still be uninfected
-long-term non-progressors: infected but disease doesn’t/slowly progresses
HIV resistance theory
-host traits preventing HIV-1 entry into cells reduce chance of infection/slow or eliminate the development if infection occurs
HIV stages
-1: acute HIV infection
-2: chronic HIV infection
-3: acquired immunodeficiency syndrome (AIDS)
HIV stage 1 (acute HIV infection)
-large amount HIV in blood
-very contagious
-flu-like symptoms
HIV stage 2 (chronic HIV infection)
-aka asymptomatic HIV infection/clinical latency
-HIV still active and reproducing in body
-may not have symptoms or get sick but can still transmit
-if HIV in blood increases, can move to stage 3
-without treatment can last a decade or progress even faster
HIV stage 3 (AIDS)
-may never reach this stage with proper HIV treatment
-high viral load, easily transmit to others
-damaged immune system, prone to opportunistic infections or serious illnesses
-without treatment only survive 3 years
HIV symptoms
-flu-like 2-4 weeks after infection
-symptoms last for a few days or weeks
-can be asymptomatic
-fever, sore throat, night sweats, mouth ulcers, chills, rash, swollen lymph nodes, muscle aches, fatigue
HIV early symptomatic stage other possible infections
-decrease in CD4+ T cells
-unusual infections, high fever, diarrhea more than a month, some cancers, peripheral neuropathy
-susceptible to secondary infections: thrush (oral candidiasis), persistent vaginal candidiasis, listeriosis, shingles
HIV AIDS other possible infections
-opportunistic infection: pneumocystis jirovecii or candidiasis of esophagus, trachea, bronchi, lungs
-unusual cancers: Kaposi’s sarcoma
HIV targets
-CD4+ T cells and replicates rapidly
-viral load: concentration of virus in the blood
HIV clinical progression four stages
-primary (including seroconversion)
-clinical latency (slow steady loss of T cells)
-early symptomatic disease
-AIDS (acquired immunodeficiency syndrome)
HIV transmission
-incubation period: 9 months to 20+ years (average 12 years)
-through sexual contact (vaginally, orally, anally) or direct contact with body fluids (blood transfusion or sharing drug needles)
HIV tests
-antibody test
-antigen/antibody test
-nucleic acid test (NAT)
HIV antibody test
-tests for antibodies to HIV in blood or oral fluid
-only HIV self-test approved by FDA
HIV antibody/antigen test
-looks for HIV antibodies and antigens
-recommended for testing in lab
-uses blood from finger
HIV nucleic acid test (NAT)
-look for actual virus in blood
-detect HIV sooner than other tests
-for those with recent exposure and early symptoms of HIV but test negative with other 2 tests
HIV treatment
-antiretroviral drugs
-target important points in replication cycle
HIV treatment
-antiretroviral drugs
-target important points in replication cycle
HIV most common in
men (80%)
HIV decrease
-17% from 2019 to 2020
-due to disruption in care services,hesitancy to go to care services and shortages in materials for testing due to COVID
HIV and reemerging diseases
-global spread of HIV/AIDS has increased number of immunocompromised persons -> reemergence of infectious disease once “under control”
-AIDS patients highly susceptible to many organisms (mycobacterium tuberculosis included)
microbiome risks
-microbiota may escape from niche and cause disease
-opportunistic pathogens among microbiota cause disease in immunocompromised hosts
s agalactiae (streptococcus)
-vaginal flora
-infections: septicemia, meningitis, pneumonia, osteomyelitis
-common population: newborns (especially vaginal birth)
s pneumoniae (streptococcus)
-upper respiratory tract
-infections: meningitis, otitis media, pneumonia, sepsis
-common population: children, elderly, immunocompromised, asplenic
s pyogenes (streptococcus)
-skin, throat
-infections: pyogenic infections, toxin-mediated infections, autoimmune sequelae, necrotizing fasclitis
-common population: children
viridans group streptococci
-oral cavity
-infections: s mutans and s mitis: dental caries, subacute bacterial endocarditis, s sanguinis: subacute endocarditis on damaged heart valves
-common population: damaged heart valve patients
first infections of streptococcus
-described by Hippocrates
-description by Theodor Billroth, associated with wound infections and erysipelas (more surface layers of skin)
streptococcus epidemiology
-carrier state: nasopharynx
-s. pyogenes or s. agalactiae: 5-15%
-s. pneumoniae: 20-40%
s. pyogenes respiratory disease peak
-6 years old and 13 years old
-most common late winter and early spring
streptococcus infectious agent description
-streptococcus spp.
-non motile
-gram +
-chains/pairs